Skip to content

D&A at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$252K-34.2%
Americold Realty Trust logo
Americold Realty TrustCOLD
$91.66M+3.0%
Laureate Education, Inc. logo
Laureate Education, Inc.LAUR
$22.58M+40.5%
Origin Bancorp logo
Origin BancorpOBK
$3.78M-27.9%
Virtu Financial logo
Virtu FinancialVIRT
$16.43M+3.1%
Dropbox logo
DropboxDBX
$39.1M+2.6%

Other financials

Income statement

See full
Revenue$282.5M+20.2%
Gross profit-$311.7M-36.4%
Operating income-$989.5M-43.0%
Net income-$1.0B-181%
EPS (diluted)-$3.46-43.6%

Balance sheet

See full
Cash & equivalents$765.7M-58.7%
Total debt$3.9B+51.5%
Total equity-$351.4M-111%
Total assets$7.5B-18.8%

Cash flow

See full
Operating cash flow-$1.2B-177%
CapEx$253.2M+57.0%
Free cash flow-$1.4B-144%

Valuation

See full
Market cap$2.03B-57.4%
Enterprise value$5.14B-22.5%
P/S1.5×-4.0×

Profitability

See full
Gross margin-95.6%-8.3pp
Operating margin-271.1%-46.9pp
Net margin-239.8%-27.6pp
FCF margin-331.8%+13.5pp

Returns & leverage

See full
Return on equity-117.6%+947pp
Debt / equity5.4×+4.8×
Current ratio-2.3×

Where this comes from

Reported directly by Lucid Group, Inc. in its filing.

Tagged under the XBRL concept lcid:DepreciationAndAmortizationExcludingDebtDiscountsAndInsurancePremiums.

The official record: Lucid Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Group, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Group, Inc.'s D&A?
Lucid Group, Inc. (LCID) reported D&A of $116.41M in Q1 2026.
How has Lucid Group, Inc.'s D&A changed year-over-year?
Lucid Group, Inc.'s D&A increased by 18.8% year-over-year, from $97.96M to $116.41M.
What is the long-term trend for Lucid Group, Inc.'s D&A?
Over 4 years (2021 to 2025), Lucid Group, Inc.'s D&A has grown at a 63.7% compound annual growth rate (CAGR), from $62.91M to $451.27M.
What does D&A mean?
Represents the non-cash allocation of the cost of tangible and intangible assets over their estimated useful lives. This metric reflects the ongoing consumption of capital investments required to support manufacturing and technology development operations.